Peptide Analysis & Quality Control

How to read a peptide certificate of analysis (COA): a complete guide

Understanding peptide purity, identity, net peptide content, HPLC chromatograms, and laboratory testing documentation.

Published 20 October 2026 By the Sycamore Analytical Research Team 12 min read
All insights Reading a COA

What is a peptide certificate of analysis?

A peptide Certificate of Analysis is a laboratory document reporting analytical results obtained from a specific peptide sample or batch. A COA may include information about the material's identity, chromatographic purity, quantitative peptide content, and other quality attributes.

For researchers, manufacturers, distributors, and quality-control professionals, understanding how to interpret these results is essential. However, not all peptide COAs contain the same information, and not every reported measurement answers the same scientific question.

A certificate reporting 99% peptide purity does not automatically establish that the vial contains the correct quantity of peptide, is free from contaminants, or meets every applicable quality specification.

This guide explains how to evaluate a peptide COA, what common analytical measurements mean, and which details deserve closer examination.

1. Start with the sample and batch information

Before reviewing purity percentages or chromatograms, verify that the certificate corresponds to the material being evaluated. A peptide COA should provide sufficient information to identify the sample and connect the analytical results to the appropriate material.

COA fieldWhy it matters
Peptide nameIdentifies the material submitted for testing
Sample or accession numberConnects the report to laboratory records
Batch or lot numberSupports traceability to manufacturing or packaging records
Sample descriptionIdentifies the material's physical form and relevant characteristics
Date receivedDocuments when the laboratory received the sample
Analysis or report dateEstablishes the timing of the reported analysis
Laboratory identityIdentifies the organization responsible for testing

Why batch traceability matters

A certificate is meaningful only when its connection to the tested material can be established. A COA associated with one manufacturing lot does not automatically establish the quality of another lot of the same peptide.

Similarly, a report generated from a single submitted vial does not independently demonstrate that every vial in a production batch has identical characteristics. The representativeness of a test result depends on sampling procedures, batch consistency, and supporting quality documentation.

Key takeaway. Verify the sample identity and lot information before interpreting any analytical percentage.

2. Understanding peptide identity testing

Identity testing evaluates whether the expected peptide is present in the submitted sample. Peptides are composed of amino acid sequences, and their chemical structures determine their molecular characteristics.

Mass spectrometry is commonly used to support peptide identification by measuring mass-to-charge ratios. Depending on the method, additional information may be obtained through fragmentation analysis or other structural characterization techniques.

What does a passing identity result mean?

A passing identity result indicates that the sample satisfied the identification criteria established for the analytical method. However, identity confirmation alone does not establish:

  • Chromatographic purity
  • Accurate peptide quantity
  • Absence of related impurities
  • Sterility
  • Endotoxin levels
  • Overall suitability for a particular application

A sample can contain the expected peptide and still fail another quality specification.

Can HPLC confirm peptide identity?

Chromatographic retention time can provide supporting identification information when compared with an appropriate reference material. However, retention time alone is generally not sufficient to conclusively establish the molecular identity of a peptide.

HPLC with diode-array detection can provide additional spectral information, but its identification capability differs from that of mass spectrometry. The appropriate technique depends on the intended analytical purpose.

3. How to interpret HPLC peptide purity

High-Performance Liquid Chromatography is widely used to evaluate peptide-related impurities. During analysis, the sample passes through a chromatographic column that separates components according to their interactions with the stationary and mobile phases. A detector measures the separated components and generates a chromatogram.

Under a common UV area-normalization approach, the principal peptide peak area is divided by the total included chromatographic peak area.

Example of an HPLC purity calculation

ComponentRelative integrated area
Principal peptide peak99.2%
Additional integrated peaks0.8%
Total100%

In this illustrative example, the reported HPLC area purity would be 99.2%. However, this result describes relative detector response under the specified analytical conditions. It does not necessarily mean that 99.2% of the total powder mass consists of the target peptide.

Other components, including water, counterions, residual solvents, or formulation excipients, may contribute to the sample's mass without being adequately represented in a routine peptide purity chromatogram.

Why HPLC purity values can differ between laboratories

Different laboratories may use different chromatographic columns, mobile phases, gradients, detection wavelengths, or integration procedures. These differences can influence impurity separation and reported purity.

A method that resolves additional impurity peaks may produce a lower main-peak area percentage than a method in which those components overlap. However, a lower purity result may also reflect genuine material differences, degradation, or analytical problems. Significant discrepancies should be investigated rather than dismissed.

4. What is net peptide content?

Net peptide content refers to the measured quantity of target peptide present in a sample. For lyophilized peptide materials, it may be reported in milligrams per vial. This measurement differs from chromatographic purity.

Consider a hypothetical vial labeled as containing 10 mg of peptide. The laboratory reports:

MeasurementResult
HPLC area purity99.1%
Net peptide content9.3 mg
Nominal content10.0 mg

These results are not inherently contradictory. The sample may exhibit high relative chromatographic purity while containing less target peptide than the nominal quantity. The measured content in this example is 93% of the stated 10 mg amount.

Whether that result passes or fails depends on the applicable, scientifically justified specification.

How is net peptide content determined?

Quantitative peptide analysis may use calibrated chromatography with an appropriately characterized reference standard. The analytical procedure must be suitable for its intended purpose.

Relevant considerations include calibration, specificity, accuracy, precision, sample preparation, and the reporting basis. A simple HPLC peak-area percentage cannot automatically be converted into milligrams of peptide per vial.

5. How to read an HPLC chromatogram

A chromatogram is one of the most useful supporting documents associated with an HPLC purity result. It provides a visual representation of the detector response over the course of an analytical separation.

PRINCIPAL PEPTIDE PEAK impurity impurity retention time TIME → RESPONSE
Illustrative only. A conceptual trace drawn to label the parts of a chromatogram. It is not laboratory data, not a Sycamore result, and not to scale.

Retention time

Retention time indicates when a component elutes from the chromatographic column. A peak's retention time can assist with identification when evaluated against a suitable reference and validated method.

Main peptide peak

The principal peak is typically associated with the target peptide. However, its assignment should be supported by appropriate identification evidence.

Additional peaks

Additional peaks may represent peptide-related impurities, degradation products, other detectable components, or analytical artifacts. Their presence does not automatically establish the identity of those substances.

Peak area

Peak area represents integrated detector response. For area-normalization methods, the relative areas of included peaks are used to calculate the reported percentage.

Baseline and integration

Chromatographic software determines where peaks begin and end. Integration parameters can affect reported peak areas, particularly when peaks overlap or have low signal intensity.

When interpreting a chromatogram, researchers should consider whether the method adequately separates relevant components and whether the integration approach is scientifically justified.

6. What does an unknown UV-active peak mean?

Some peptide COAs include comments describing additional UV-active peaks. These are detector signals that appear apart from the principal chromatographic peak. Potential explanations include:

  • Peptide-related impurities
  • Oxidation or other degradation products
  • Sample constituents with UV absorption
  • Sample preparation artifacts
  • Chromatographic or instrument-related interference

UV detection alone generally cannot establish the chemical identity of an unknown component. Additional characterization, potentially involving LC-MS, may be required.

An unidentified peak should not automatically be treated as harmless, nor should it be assigned a specific chemical identity without supporting evidence.

7. Why a COA may include multiple analytical tests

Peptide characterization can involve several complementary measurements.

Analytical testInformation provided
IdentityEvidence supporting the presence of the expected peptide
HPLC purityRelative chromatographic composition under a defined method
Net peptide contentQuantitative amount of target peptide
MoistureWater content
EndotoxinBacterial endotoxin level
Residual solventsSpecified solvent residues
SterilityResult of a suitable sterility test under its defined conditions

Not every research sample requires every possible analytical test. The appropriate testing program depends on the material, specifications, and intended research application.

Importantly, one test cannot substitute for an unrelated measurement. A passing peptide identity result does not establish acceptable endotoxin levels. Likewise, a high HPLC purity percentage does not establish sterility.

8. How to identify potential warning signs on a peptide COA

A laboratory report should be evaluated for completeness, traceability, and scientific consistency. Potential concerns include:

  • Missing sample identification. Without sufficient identifying information, it may be difficult to establish which material was tested.
  • No analytical method information. A numerical result without method context can be difficult to interpret.
  • Purity and content presented interchangeably. These are distinct analytical measurements.
  • Unexplained chromatographic peaks. Unexpected signals may warrant further review or characterization.
  • Unclear acceptance criteria. A reported result should not automatically be described as passing without an applicable specification.
  • Inconsistent sample or lot information. Differences between the certificate and associated manufacturing records require clarification.
  • Unsupported accreditation or regulatory claims. Laboratory credentials should be independently verifiable.

None of these observations alone proves that a certificate is fraudulent or scientifically invalid. They are reasons to request additional documentation or clarification.

9. How to verify a peptide certificate of analysis

When reviewing a third-party COA, research organizations should consider a structured verification process.

  1. Confirm the issuing laboratory. Verify that the laboratory exists and that its identity and contact information correspond to the report.
  2. Confirm the report. Where verification services are available, confirm that the report number and relevant details match the laboratory's records. Sycamore report IDs can be checked here, without an account.
  3. Verify sample traceability. Confirm the relationship between the tested sample, lot number, and material being evaluated.
  4. Review the analytical methods. Determine what each test measures and whether the method is appropriate for the reported result.
  5. Evaluate the supporting data. Request chromatograms, peak tables, or other appropriate analytical records when needed.
  6. Compare results with specifications. Determine whether results meet documented acceptance criteria applicable to the material.
  7. Investigate discrepancies. If multiple laboratories report conflicting results, review sample handling, method differences, and underlying analytical evidence.

A COA should be treated as an analytical record — not as a substitute for comprehensive quality evaluation.

10. What should a professional peptide COA include?

A well-documented analytical report may contain:

  1. Issuing laboratory identification and report number
  2. Sample description and unique identifier
  3. Relevant batch or lot information
  4. Dates of sample receipt and analysis
  5. Test names and analytical methods
  6. Results with appropriate units
  7. Applicable specifications or acceptance criteria, where provided
  8. Relevant method or result limitations
  9. Report authorization or approval
  10. Supporting data or a means to request it, where appropriate

The precise format depends on the laboratory's procedures, scope of testing, and reporting requirements. Not every certificate must use an identical template.

11. Why independent COA verification matters

Independent analytical testing can provide useful additional information about peptide materials. However, independence alone does not guarantee the accuracy or completeness of an analytical result.

Reliable laboratory testing depends on appropriate analytical methods, suitable instrumentation, qualified personnel, sample integrity, and defensible interpretation.

For manufacturers and research organizations, independent testing can support supplier qualification, batch assessment, discrepancy investigations, and research procurement decisions.

When laboratory results disagree, the goal should be to understand the scientific basis of the discrepancy — not simply to select the highest reported purity percentage.

12. Sycamore Analytical's approach to peptide characterization

At Sycamore Analytical, our analytical focus includes peptide identity, chromatographic purity, and quantitative peptide-content evaluation.

We recognize that meaningful laboratory reporting requires more than displaying a numerical result. Analytical findings should be interpreted in the context of the sample, the method used, and the scientific limitations of the measurement.

Our objective is to support research organizations with clear analytical information and a responsible approach to laboratory data interpretation. For organizations evaluating peptide materials, understanding the difference between identity, purity, and content is an essential first step toward informed quality assessment.

Frequently asked questions

What does COA stand for in peptide testing?

COA stands for Certificate of Analysis. It is a document reporting analytical findings for a particular sample or batch.

Does a peptide COA prove the material is 99% pure?

A COA may report 99% chromatographic purity for the tested sample under a particular method. The significance of that result depends on the analytical procedure, supporting data, and sample traceability.

Can a peptide pass identity testing but fail purity testing?

Yes. Identity and purity measure different characteristics. A sample may contain the expected peptide while also containing impurities above its specified limit.

Is HPLC purity the same as peptide content?

No. HPLC area purity describes relative chromatographic detector response, while peptide content is a quantitative measurement of the amount of target peptide.

Should a peptide COA include a chromatogram?

A chromatogram is valuable supporting evidence for chromatographic testing. Whether it is included directly in the certificate depends on laboratory reporting practices and applicable requirements.

Can two laboratories produce different COAs for the same peptide?

Yes. Analytical methods, sample preparation, instrument conditions, and actual sample differences can influence reported results.

Does a COA guarantee a peptide is safe for human use?

No. A research-material COA does not establish suitability, approval, or safety for human or veterinary administration.

Conclusion: understanding a COA requires more than reading the purity percentage

A peptide Certificate of Analysis can provide valuable information about research material identity, purity, and quantitative composition. However, the meaning of each result depends on the analytical method, sample evaluated, and supporting documentation.

A high purity percentage does not independently establish accurate peptide content or the absence of other quality concerns. For researchers, manufacturers, and quality-control teams, the most reliable approach is to evaluate the complete analytical context.

The value of a COA lies not simply in the numbers it reports, but in the scientific evidence supporting those numbers.

Learn more about peptide analytical testing. Sycamore Analytical focuses on clear analytical reporting and scientifically grounded peptide characterization. For available testing and sample requirements, submit a sample or write to support@sycamoreanalytical.com.

Scientific references

  1. U.S. Food and Drug Administration. Q2(R2) Validation of Analytical Procedures.
  2. U.S. Food and Drug Administration. Q14 Analytical Procedure Development.
  3. United States Pharmacopeia. General Chapter <621>: Chromatography.
  4. U.S. Food and Drug Administration. Analytical Procedures and Methods Validation for Drugs and Biologics.
  5. International Council for Harmonisation. Q14 Analytical Procedure Development. Adopted 1 November 2023.

Scientific notice. This article is intended for educational and analytical science purposes. It does not certify any specific product or laboratory. References to FDA, USP, or ICH materials do not imply regulatory approval, accreditation, or endorsement of Sycamore Analytical. Laboratory services and analytical capabilities should be confirmed directly with the organization.